These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30337529)

  • 1. Substantiating freedom from parasitic infection by combining transmission model predictions with disease surveys.
    Michael E; Smith ME; Katabarwa MN; Byamukama E; Griswold E; Habomugisha P; Lakwo T; Tukahebwa E; Miri ES; Eigege A; Ngige E; Unnasch TR; Richards FO
    Nat Commun; 2018 Oct; 9(1):4324. PubMed ID: 30337529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of the eradicability of filarial infections: a conceptual approach.
    Duerr HP; Dietz K; Eichner M
    Trends Parasitol; 2005 Feb; 21(2):88-96. PubMed ID: 15664532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.
    Gambhir M; Bockarie M; Tisch D; Kazura J; Remais J; Spear R; Michael E
    BMC Biol; 2010 Mar; 8():22. PubMed ID: 20236528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination.
    Michael E; Sharma S; Smith ME; Touloupou P; Giardina F; Prada JM; Stolk WA; Hollingsworth D; de Vlas SJ
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006674. PubMed ID: 30296266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping, monitoring, and surveillance of neglected tropical diseases: towards a policy framework.
    Baker MC; Mathieu E; Fleming FM; Deming M; King JD; Garba A; Koroma JB; Bockarie M; Kabore A; Sankara DP; Molyneux DH
    Lancet; 2010 Jan; 375(9710):231-8. PubMed ID: 20109924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic filariasis and onchocerciasis.
    Taylor MJ; Hoerauf A; Bockarie M
    Lancet; 2010 Oct; 376(9747):1175-85. PubMed ID: 20739055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate parasitic diseases.
    Behbehani K
    Bull World Health Organ; 1998; 76 Suppl 2(Suppl 2):64-7. PubMed ID: 10063677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting lymphatic filariasis elimination in data-limited settings: A reconstructive computational framework for combining data generation and model discovery.
    Smith ME; Griswold E; Singh BK; Miri E; Eigege A; Adelamo S; Umaru J; Nwodu K; Sambo Y; Kadimbo J; Danyobi J; Richards FO; Michael E
    PLoS Comput Biol; 2020 Jul; 16(7):e1007506. PubMed ID: 32692741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission models and management of lymphatic filariasis elimination.
    Michael E; Gambhir M
    Adv Exp Med Biol; 2010; 673():157-71. PubMed ID: 20632536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continental-scale, data-driven predictive assessment of eliminating the vector-borne disease, lymphatic filariasis, in sub-Saharan Africa by 2020.
    Michael E; Singh BK; Mayala BK; Smith ME; Hampton S; Nabrzyski J
    BMC Med; 2017 Sep; 15(1):176. PubMed ID: 28950862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, Lymphatic Filariasis.
    Singh BK; Michael E
    Parasit Vectors; 2015 Oct; 8():522. PubMed ID: 26490350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parasitic infections in Singapore.
    Singh M
    Ann Acad Med Singap; 1987 Oct; 16(4):689-95. PubMed ID: 3328557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda.
    Luroni LT; Gabriel M; Tukahebwa E; Onapa AW; Tinkitina B; Tukesiga E; Nyaraga M; Auma AM; Habomugisha P; Byamukama E; Oguttu D; Katabarwa M; Unnasch TR
    PLoS One; 2017; 12(12):e0189306. PubMed ID: 29253862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and monitoring of onchocerciasis in Latin America.
    Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
    Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical models and lymphatic filariasis control: endpoints and optimal interventions.
    Michael E; Malecela-Lazaro MN; Kabali C; Snow LC; Kazura JW
    Trends Parasitol; 2006 May; 22(5):226-33. PubMed ID: 16564745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lymphatic filariasis in Republic of Congo and scrotal elephantiasis].
    Carme B
    Bull Soc Pathol Exot; 2005 Dec; 98(5):363-4. PubMed ID: 16425714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling lymphatic filariasis transmission and control: modelling frameworks, lessons learned and future directions.
    Stolk WA; Stone C; de Vlas SJ
    Adv Parasitol; 2015 Mar; 87():249-91. PubMed ID: 25765197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographical distribution and species identification of human filariasis and onchocerciasis in Bioko Island, Equatorial Guinea.
    Ta TH; Moya L; Nguema J; Aparicio P; Miguel-Oteo M; Cenzual G; Canorea I; Lanza M; Benito A; Crainey JL; Rubio JM
    Acta Trop; 2018 Apr; 180():12-17. PubMed ID: 29289559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis.
    Michael E; Singh BK
    BMC Med; 2016 Jan; 14():14. PubMed ID: 26822124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.